Stock Market

Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment

• What: Every Cure's drug repurposing strategy involves repurposing existing drugs for rare diseases, rather than developing new ones.
• Why: This approach aims to accelerate treatment development and reduce costs by leveraging existing safety and efficacy data.
• Signal: Preliminary results from Every Cure's efforts suggest that repurposed drugs can be effective in treating rare diseases.
• Target: The non-profit is currently focusing on **10** rare diseases, with a goal of identifying effective treatments within the next **5** years.
• Risk: One potential risk of this approach is that repurposed drugs may not be specifically approved for rare diseases, potentially limiting their adoption.